CNCE

Concert Pharmaceuticals, Inc.

Delisted

CNCE was delisted on the 3rd of March, 2023.

50 hedge funds and large institutions have $58M invested in Concert Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
16
Reduced
10
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
JPMorgan Chase & Co
51
JPMorgan Chase & Co
New York
-$3.06M -227,250 Closed
BC
52
Broadfin Capital
New York
-$2.69M -200,000 Closed
Marshall Wace
53
Marshall Wace
United Kingdom
-$807K -60,000 Closed
RSCM
54
Rock Springs Capital Management
Maryland
-$801K -59,553 Closed
FCM
55
Farallon Capital Management
California
-$790K -58,700 Closed
State Street
56
State Street
Massachusetts
-$590K -43,859 Closed
JC
57
JBF Capital
Colorado
-$559K -41,556 Closed
SCA
58
SAC Capital Advisors
Connecticut
-$432K -32,118 Closed
NFA
59
Nationwide Fund Advisors
Ohio
-$198K -14,746 Closed
CS
60
Credit Suisse
Switzerland
-$174K -12,910 Closed
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
-$163K -12,100 Closed
TA
62
Teachers Advisors
New York
-$91K -6,750 Closed
SSG
63
Summit Securities Group
New York
-$13K -1,000 Closed